Latest news
Invitation to Korean companies
In April, 2023, Måns Österberg, Director Alliance Management will visit our collaboration partners in Korea to develop the projects further. There will…
Press releases
Jul 13, 2023, 08:15
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
Jun 19, 2023, 08:15
News
IR
English
Corporate Action
Other
Jun 19, 2023, 08:15
News
IR
Swedish
Corporate Action
Other
Jun 09, 2023, 08:30
News
IR
English
Corporate Action
Other
Jun 09, 2023, 08:30
News
IR
Swedish
Corporate Action
Other
Jun 01, 2023, 08:45
News
IR
Swedish
Corporate Action
Other
Jun 01, 2023, 08:45
News
IR
English
Corporate Action
Other
May 26, 2023, 16:50
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 22, 2023, 08:30
News
IR
English
Regulatory
MAR
Corporate Action
Other
May 22, 2023, 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
May 11, 2023, 08:30
News
IR
English
Corporate Action
Other
May 11, 2023, 08:30
News
IR
Swedish
Corporate Action
Other
Apr 28, 2023, 09:51
News
IR
Swedish
Correction
Regulatory
MAR
Report
Interim
Q1
mfn-cus-disclaimer
Apr 28, 2023, 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 28, 2023, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
mfn-cus-disclaimer
Apr 20, 2023, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Apr 14, 2023, 08:45
News
IR
Swedish
Corporate Action
Other
Apr 14, 2023, 08:45
News
IR
English
Corporate Action
Other
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se